Anipryl (selegiline hydrochloride tablets)

أنيبريل أقراص سيليجيلين هيدروكلوريد للكلاب لعلاج الخرف البيطري ومتلازمة كوشينغ

Compare
Pharmaceutical Tablet

Anipryl (selegiline hydrochloride, L-deprenyl hydrochloride) is an oral selective monoamine oxidase type B (MAO-B) inhibitor indicated for the control of clinical signs associated with canine cognitive dysfunction syndrome (CDS) and the control of clinical signs associated with uncomplicated canine pituitary-dependent hyperadrenocorticism (PDH / Cushing's disease).

Dosage Form

Tablet

Product Type

Pharmaceutical

Manufacturer

Zoetis

Package

Bottles of 30 tablets containing 2 mg, 5 mg, 10 mg, 15 mg, or 30 mg selegiline HCl

Dosages

Species Dosage Route Duration
Dog For CDS: 0.5 to 1.0 mg/kg once daily in the morning; For PDH: 1.0 mg/kg once daily in the morning, may be increased to 2.0 mg/kg if needed Oral Administer daily in the morning. Re-evaluate response at 4 weeks and 8 weeks

Withdrawal Periods

No withdrawal information available.

Indications

  • Control of clinical signs associated with canine cognitive dysfunction syndrome (CDS).

  • Control of clinical signs associated with uncomplicated canine pituitary-dependent hyperadrenocorticism (PDH / Cushing's disease).

Contraindications

  • Contraindicated in dogs with known hypersensitivity to selegiline hydrochloride.

  • Do not use concurrently with meperidine, tramadol, other opioids, SSRIs, tricyclic antidepressants, or amitraz.

Precautions

  • Allow at least 14 days washout period after discontinuation of fluoxetine or tricyclic antidepressants before starting Anipryl. Concurrent use with alpha-2 agonists requires careful monitoring.

Side Effects

  • Vomiting, diarrhea, restlessness, agitation, anorexia, lethargy, or salivation.

Images

Documents

  • Anipryl (selegiline hydrochloride tablets) Prescribing Information

    Leaflet
    Download

Active Ingredients

Diseases

No diseases linked.

Related Products

No data available

Information has not been added yet.

Related Products By Active Ingredient

No data available

Information has not been added yet.

Companies

Alternatives

No alternatives available.

This website uses cookies to ensure you get the best experience.